Innate lymphoid cells type 2 in LTP-allergic patients and their modulation during sublingual immunotherapy
Allergy
.
2021 Jul;76(7):2253-2256.
doi: 10.1111/all.14745.
Epub 2021 Feb 6.
Authors
Francisca Palomares
1
,
Francisca Gómez
2
,
Gádor Bogas
2
,
Laura Maggi
3
,
Lorenzo Cosmi
3
,
Francesco Annunziato
3
,
Rafael Núñez
1
,
Natalia Pérez
2
,
Rosa Muñoz-Cano
4
5
,
María José Torres
2
6
,
Cristobalina Mayorga
1
2
Affiliations
1
Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
2
Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
3
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
4
Allergy Section, Pneumology Department, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain.
5
Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
6
Medicine Department, Universidad de Málaga-UMA, Málaga, Spain.
PMID:
33476397
PMCID:
PMC8359238
DOI:
10.1111/all.14745
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Allergens
Animals
Humans
Hypersensitivity* / therapy
Immunity, Innate
Immunotherapy
Lymphocytes
Pyroglyphidae
Rhinitis, Allergic*
Sublingual Immunotherapy*
Substances
Allergens